🇺🇸

Broad Market

US SEC Filing Intelligence · 519 digests

New to these filings? Learn what an 8-K is

· monthly

US Pre-Market SEC Filings Roundup — September 03, 2026

This overnight filing cycle is dominated by a surge in SPAC activity, with four major business combination announcements (PlusAI, Remix Therapeutics, Ursa Major, Elroy Air) signaling a potential resurgence in the de-SPAC market. A significant capital allocation theme emerges from large-scale share repurchase programs at Toyota (JPY 1 trillion) and ORIX (¥250 billion), indicating strong corporate confidence in undervaluation. The biotech sector presents a stark contrast, with Passage BIO's cash-burning pre-revenue status and a major licensing deal between HUTCHMED and GSK, highlighting the sector's binary risk/reward profile. Insider selling is concentrated in the technology sector, with multiple executives at Rackspace Technology and RxSight reducing their holdings, which warrants caution. A notable related-party acquisition by Scienjoy Holding and a highly dilutive financing structure for Ribbon Acquisition Corp. present complex risk/reward scenarios for investors.

27 high priority 23 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — September 02, 2026

The September 2, 2026, filings reveal a market bifurcated between aggressive corporate action and underlying financial distress. A clear theme is the pursuit of growth through M&A, with large-cap industrial Vertiv ($1.45B deal for UIG) and smaller players like EVI Industries, cbdMD, and SPACs leading the charge, while G-III Apparel strengthens its portfolio via the Marc Jacobs acquisition. Countering this, a wave of financing events—from stock offerings (PMV Pharmaceuticals) and dilutive note agreements (Senti Biosciences, VolitionRx) to a significant SPAC deal termination (Quantumsphere Acquisition)—highlights acute capital constraints, particularly in the biotech and small-cap space. Operational results are mixed; Daktronics shows a 21% YoY EPS jump but a 20% YoY slump in new orders, signaling potential future revenue headwinds. A massive shakeup in leadership is also underway, with significant C-suite and board changes at major firms like Lowe's, Hershey, and AIG, alongside a wave of director resignations at smaller firms. The period-over-period data, where available, points to margin expansion for some (G-III's 440bps gross margin improvement) but growing stress in order books and balance sheets for others, suggesting investors should prioritize companies with strong operational momentum and clear, executable strategies over those relying on external financing for survival.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — September 02, 2026

This digest covers 48 filings from September 2, 2026, dominated by corporate distress signals (insolvencies, delistings, asset sales) and deal-making (M&A, SPAC activity, open offers). A key theme is the high failure rate of SPACs, with Quantumsphere Acquisition Corp terminating its merger and significant redemptions at D. Boral ARC Merger Corp (96% of public shares redeemed). The Indian market shows a surge in insolvency filings (Parsvnath, Astron Paper, Baron Infotech) and a notable failed open offer for Bliss GVS Pharma, where only 0.00% of the target shares were tendered. Conversely, there is active capital deployment in renewable energy (India Cements) and specialty chemicals (Fine Organic Industries), alongside several new SPAC IPOs raising over $395 million. The data reveals a bifurcated market: distressed entities are liquidating or restructuring, while well-capitalized firms pursue strategic acquisitions and growth investments.

48 high priority 48 total filings
· daily

US SEC Filings Daily Market Digest — September 02, 2026

Today's digest (Sept 2, 2026) reveals a market bifurcated between aggressive growth investments and defensive capital returns. The standout theme is a massive, coordinated equity award to TSMC's top management, signaling strong retention and confidence in future execution, while Sea Ltd's C-suite selling under 10b5-1 plans provides a contrasting note of caution. In the SPAC and small-cap space, deal risk is elevated, with Quantumsphere's merger termination and Nuburu's 1-for-40 reverse split highlighting distress. On the positive side, Bitdeer's $100M land acquisition for AI/HPC infrastructure and GitLab's 21% revenue growth (despite widening losses) show capital being deployed for long-term growth. Capital returns are steady, with Vertiv declaring a dividend and News Corp continuing its $1B buyback. The overall picture is one of selective opportunity, with a clear preference for companies with strong secular tailwinds (AI, cloud, semiconductors) over those with uncertain deal outcomes or dilutive financing structures.

29 high priority 21 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — September 02, 2026

Overnight filings reveal a market bifurcated between aggressive insider buying at micro-cap biotech Quoin Pharmaceuticals and significant insider selling at high-growth industrials like Coherent and Standex, signaling divergent management conviction. The most material corporate event is the termination of the Quantumsphere Acquisition Corp. SPAC merger, a high-risk signal for the de-SPAC market. A notable sector theme is the concentrated insider buying in the biotech/pharma space, particularly at Quoin and Waste Energy, contrasting with routine insider selling for tax purposes at larger caps. Capital allocation is mixed, with Vertiv declaring a modest dividend while VolitionRx continues dilutive convertible note conversions. The Skyworks-Qorvo merger extension provides a key catalyst to monitor, while the HDFC Bank and ICICI Bank credit rating updates offer a positive signal for Indian financials. Overall, the data suggests a cautious market with selective, high-conviction bets in small-cap value and biotech, while large-cap tech and industrial insiders are reducing exposure.

34 high priority 16 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — September 01, 2026

This Material Events Monitor digest covers 50 SEC filings from September 1, 2026, revealing a market landscape dominated by major capital allocation events, strategic divestitures, and significant financing activities. Key period-over-period trends include strong revenue growth in the energy services sector (Hornbeck Offshore +12.3% YoY) and digital infrastructure (GitLab +21% YoY), contrasted with margin compression at GitLab (GAAP operating margin worsened to -20% from -8% YoY) and mixed signals from the hospitality sector following Ryman's $1.38B acquisition. The most critical developments include Yum! Brands' $2.7B Pizza Hut divestiture, Red Robin's $96M refranchising, and Moderna's $2.0B convertible note offering, signaling a broad corporate focus on portfolio optimization and balance sheet restructuring. A notable pattern is the surge in debt financing across sectors—from Caterpillar's $1.7B facility to TPG's $1.5B credit line—suggesting companies are locking in favorable terms ahead of potential rate changes. Insider activity is limited but includes voluntary RSU cancellations at Exodus Movement to support strategic integration, while forward-looking guidance from Ryman and GitLab provides key catalysts for Q3 2026.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — September 01, 2026

This digest covers 50 filings from September 1, 2026, dominated by a wave of corporate distress and restructuring. The most critical theme is a cluster of bankruptcy, delisting, and going-concern warnings, headlined by **BioXcel Therapeutics** (Chapter 11, 10/10 materiality) and **NCS Multistage** (delisted, 10/10 materiality). A significant M&A cycle is underway, with **Korn Ferry** completing a ~£800M acquisition of AMS and **Helix Energy** filing financials for a potential Hornbeck Offshore acquisition, signaling sector consolidation. The SPAC space shows stress, with **Andretti Acquisition Corp. II** issuing non-redemption agreements to secure its extension vote. A notable hostile bid emerged for **Yatra Online**, which the Board unanimously rejected as undervaluing the company. Across the portfolio, negative sentiment dominates (bankruptcies, delistings, CIRPs), but selective positive signals exist in strategic acquisitions by **ITC Hotels** and **Nephrocare**. The data reveals a bifurcated market: distressed entities are liquidating or restructuring, while well-capitalized firms are deploying capital for growth.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — September 01, 2026

Today's digest reveals a market bifurcated between aggressive capital returns and significant operational stress. A clear theme is the acceleration of share buybacks, with major players like Equinor, Mizuho, News Corp, and Luckin Coffee all actively returning capital, signaling management confidence. However, this is contrasted by a wave of distress signals, including a Nasdaq deficiency notice for XTI Aerospace, a going-private transaction for Distribution Solutions Group, and a sharp drop in net income for Regis Corp due to a prior-year tax benefit. The SPAC space shows continued activity, with Bleichroeder Acquisition Corp. III taking Ursa Major public and Andretti Acquisition Corp. II scrambling to secure non-redemption agreements to extend its timeline. Insider activity is mixed: a CEO purchase at 17 Education & Technology Group is a positive signal, while a CEO sale at Sea Ltd and a 10% owner sale at Anteris Technologies suggest caution. M&A is picking up, notably Enovis's acquisition of eCential Robotics and TotalEnergies' strategic reshuffling of its renewables portfolio. Overall, the market is rewarding disciplined capital allocation and penalizing operational missteps, with a heightened focus on liquidity and going-concern risks.

22 high priority 28 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — September 01, 2026

Overnight SEC filings from August 31 to September 1, 2026, reveal a mixed market landscape with notable insider trading patterns and significant corporate actions. Key themes include a wave of insider selling by executives at Lyft, Oddity Tech, Xenon Pharmaceuticals, and Sea Ltd, contrasting with insider buying at Grocery Outlet, Hyperscale Data, and 17 Education & Technology Group. The most material developments include Regis Corp's mixed fiscal year results showing revenue growth but franchise declines, XTI Aerospace's Nasdaq deficiency notice with going concern risk, and the SPAC merger of Bleichroeder Acquisition Corp. III with Ursa Major Technologies. Capital allocation trends show Equinor and News Corp continuing buyback programs, while Mizuho Financial Group announced a significant ¥200 billion buyback. The IPO pipeline remains active with Capstone 72 and Entrata filing registration statements. Overall, the filings suggest cautious optimism in select sectors, with particular risks in small-cap and distressed companies.

28 high priority 22 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — August 31, 2026

The August 31, 2026, filing period is dominated by significant M&A activity and strategic capital allocation moves, with three major acquisitions totaling over $21 billion announced (Aon's $17B purchase of USI, ONEOK's $4.425B Brazos Midstream deal, and Ranger Energy's $27.5M coiled tubing acquisition). A clear sector theme emerges in energy and infrastructure, where companies are deploying capital for growth while simultaneously strengthening balance sheets. Several leadership transitions were announced across a broad range of companies, creating both uncertainty and opportunity. The period also saw a notable negative event with Northann Corp receiving a delisting notice, and a positive development with Trilogy Metals securing a strategic $35.6M investment from the U.S. Department of War. Period-over-period comparisons reveal a mixed picture: GameStop's operating income surged 126% YoY despite a 19% sales decline, while Zedge's free cash flow grew 55% YoY. Insider activity was limited but notable, with Zedge's Vice Chairman leading a $7.5M insider investment. Forward-looking guidance was generally positive, with Kyntra Bio extending its cash runway into Q4 2027 and TELA Bio targeting $17M in annual cost savings.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — August 31, 2026

This digest covers 50 filings from August 31, 2026, dominated by a wave of corporate control events, insolvencies, and regulatory actions. The most critical theme is a surge in M&A and open offers, particularly the high-profile acquisition of Tribhovandas Bhimji Zaveri (TBZ) by GRT Jewellers, which includes a mandatory open offer at a 19.4% premium, and the transformative merger of Happiest Minds Technologies into ITC Infotech, a deal valued at over ₹1,329 Cr for the initial stake. Concurrently, several companies are in advanced stages of financial distress, with Siti Networks (₹1,500 Cr default), MT Educare, and Punj Lloyd all under Corporate Insolvency Resolution Process (CIRP), signaling a peak in the credit cycle for stressed assets. Delisting actions are also prominent, with Cambium Networks and SES AI Corp facing final delisting, while Northann Corp is appealing a similar fate. The data reveals a bifurcated market: aggressive capital deployment by acquirers like GRT and ITC Infotech, contrasted with severe liquidity crises and regulatory non-compliance among smaller and mid-cap entities. Period-over-period comparisons, where available, show declining revenues and losses at subsidiaries like IIRM Global, reinforcing the stress theme. The overall sentiment is mixed, with high-conviction M&A providing bullish signals for target company shareholders, while the numerous defaults and delistings present significant risks.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — August 31, 2026

Today's filings reveal a market bifurcated between aggressive M&A and capital deployment by large-cap firms (Aon's $17B acquisition of USI, SLB's $3.4B acquisition of Kelvion) and significant distress signals from micro-cap companies facing delisting, dilution, and internal control failures. Period-over-period data shows a mixed earnings picture: SAIC posted 6% revenue growth but a 20% net income decline, while GameStop's operating income surged 126% YoY on a one-time gain, masking a 20% sales drop. Insider activity is a key theme, with multiple Sea Ltd executives selling over $2.7M combined under 10b5-1 plans, contrasting with bullish insider buying at Agree Realty ($1.46M) and Alzamend Neuro ($109K). Capital allocation trends are divergent, with BBVA actively buying back shares and Aon prioritizing debt repayment, while Waste Energy and Zedge pursue potentially dilutive equity-linked transactions. The most critical developments include Aon's transformative middle-market insurance play, BioMarin's favorable patent settlement, and the U.S. Department of War's strategic investment in Trilogy Metals, signaling government interest in critical minerals.

28 high priority 22 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — August 31, 2026

This morning's 50 filings reveal a market bifurcated between aggressive M&A and capital deployment by large-cap firms (Aon, SLB) and significant distress signals from smaller, cash-constrained companies (Northann, Waste Energy, Breeze Acquisition). The period-over-period data highlights a clear theme of 'growth at the expense of profitability' in the services sector, with SAIC reporting 6% revenue growth but a 20% net income decline. Insider activity is a key differentiator: bullish buys at Agree Realty and Schmid Group contrast sharply with coordinated selling at Sea Ltd, where four executives sold over $2.7M in stock under 10b5-1 plans. The forward-looking data is rich with catalysts, including multiple M&A closings in September and a major patent settlement for BioMarin that creates a new royalty stream. Capital allocation patterns are also diverging, with BBVA aggressively buying back stock while Zedge suspends its repurchase program. The most actionable intelligence centers on the Aon-USI mega-deal, the Trilogy Metals strategic investment by the Department of War, and the potential for a turnaround at Alzamend Neuro following a director's $109K insider purchase.

28 high priority 22 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — August 28, 2026

The August 28, 2026, filing cycle reveals a market landscape dominated by significant capital markets activity, corporate restructuring, and strategic pivots. A clear theme is the aggressive pursuit of capital through debt and equity, with companies like Karman Holdings ($100M loan), Boeing (new $2.25B facility), and Lockheed Martin ($2.25B facility) securing substantial credit lines, while smaller firms like Pluri Inc. and BranchOut Food conduct dilutive offerings. This suggests a bifurcated market where large, investment-grade companies are optimizing liquidity, while smaller, cash-strapped firms are forced into more expensive financing. The M&A landscape is active but with notable failures, as seen in the mutual termination of the Element Solutions/Solstice merger, contrasting with the successful completion of Energy Fuels' $243M acquisition of ASM and BitGo's acquisition of NYDIG's trading business. A significant risk cluster is forming around companies with distressed financials, including BioXcel Therapeutics' Chapter 11 filing, Direct Digital Holdings' repeated loan amendments, and Getty Images' $92.3M adverse judgment. Insider activity is sparse in the filings, but the executive compensation patterns at Hycroft Mining and Latch, Inc. indicate a focus on retention. The overall sentiment is cautious, with a high volume of neutral filings masking underlying financial stress and strategic realignment across sectors.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — August 28, 2026

This digest covers 50 filings from August 28, 2026, dominated by a surge in Nasdaq delisting and deficiency notices (11 filings), signaling a severe liquidity and compliance crisis among small-cap biotech and tech firms. The most material event is BioXcel Therapeutics' Chapter 11 bankruptcy filing with a $57.5M stalking horse bid from Teva Pharmaceuticals, creating a high-stakes auction process. In M&A, a major theme is the consolidation of the Indian cement sector via the ACC/Ambuja Cements amalgamation, alongside a significant $1.76B investment by Hero MotoCorp in EV maker Ather Energy. The SPAC sector shows continued stress, with Constellation Acquisition Corp I using its 7th extension and Allegro Merger Corp terminating its merger with SeeQC. A notable positive trend is the strong revenue growth at Cloud Wave Technologies (191% over two years) being acquired by AXISCADES, and Alara Resources Ltd's revenue surging 909% YoY, attracting investment from South West Pinnacle. Insider activity is limited in these filings, but the sheer volume of going concern and delisting risks points to a broad market cleansing event for micro-cap stocks.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — August 28, 2026

Today's digest reveals a market bifurcated between sectors facing headwinds and those with strong catalysts. The tanker and shipping sector is under pressure, with Hafnia Ltd reporting a 24.8% decline in net income, while the cybersecurity and AI infrastructure spaces show robust growth, exemplified by SentinelOne's 20.5% revenue increase. A significant wave of M&A and restructuring activity is reshaping the landscape, highlighted by BioXcel Therapeutics' Chapter 11 filing and BitGo's acquisition of NYDIG's trading business. Insider activity is mixed, with a notable CEO purchase in the struggling EdTech sector and routine tax-related sales at Marzetti Co. Capital allocation trends show a preference for share buybacks, with News Corp and Southern First Bancshares announcing new programs, while the IPO market shows signs of life with NorthStrive Acquisition Corp's $100M SPAC IPO. The most critical development is the NMPA approval of HUTCHMED's ATLED® for cholangiocarcinoma, a major catalyst for the biotech sector. Portfolio-level patterns indicate a defensive shift in capital allocation towards liquidity and debt management, as seen with Lockheed Martin's new credit facility and JBG SMITH's credit agreement amendment.

24 high priority 26 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — August 28, 2026

Overnight filings reveal a bifurcated market landscape with significant distress signals in the healthcare and technology sectors, offset by strategic capital deployment in infrastructure and energy. The most critical development is BioXcel Therapeutics' Chapter 11 filing with a stalking horse bid from Teva Pharmaceuticals, highlighting the high-risk nature of biotech. Lumentum Holdings saw a coordinated wave of insider selling by multiple top executives, including the CEO and CFO, totaling over $6.7 million, a bearish signal for the optical components sector. Conversely, a major strategic investment in VNET Group by a consortium backed by CATL signals a bullish long-term bet on Chinese data center infrastructure. Hafnia Ltd reported a 24.8% decline in net income, reflecting a challenging tanker market, while Netcapital faces a Nasdaq delisting risk due to filing delays. The overall theme is one of caution, with capital being redeployed from distressed assets into strategic long-term plays, and insider activity suggesting management concern in specific names.

36 high priority 14 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — August 27, 2026

The August 27, 2026, filing set reveals a market sharply bifurcated between aggressive capital markets activity and operational headwinds. A wave of SPAC mergers and IPOs (Bleichroeder/Pasqal, Southern Cross Acquisition II) signals renewed appetite for high-risk, high-reward tech and blank-check vehicles, while established companies like Build-A-Bear and Gap Inc. report declining revenues and lowered guidance, citing tariff impacts and shifting consumer demand. The most critical developments include a major $600 million credit facility for Core Scientific, a transformative $3.2 billion platform acquisition by Velocity Financial, and a high-stakes delisting deadline for SOBR Safe. Portfolio-level patterns show a pronounced divergence: growth-stage firms are aggressively accessing capital (often with dilutive terms), while mature companies are returning cash to shareholders via buybacks and dividends, even as their core operations soften. Insider activity is muted, with CFO transitions dominating personnel moves rather than conviction-based trading.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — August 27, 2026

The August 27, 2026, filing set is dominated by a wave of corporate actions, including a high volume of SPAC business combinations, delistings, and insolvency proceedings, creating a bifurcated market environment. A clear theme is the aggressive push into high-growth sectors like quantum computing (Bleichroeder/Pasqal), electric vehicles (Hero MotoCorp/Ather), and space technology (Black Spade/Astrum), all backed by substantial capital commitments. Conversely, a significant number of companies are facing existential threats, with multiple Nasdaq delisting notices (Lottery.com, Rein Therapeutics, SOBR Safe) and formal delistings (Forte Biosciences, Leggett & Platt) signaling a purge of non-compliant or acquired entities. The data reveals a stark contrast between capital-rich entities executing transformative deals and distressed companies struggling with regulatory compliance and financial viability. Key period-over-period trends include strong revenue growth in the EV and renewable energy sectors (Ather Energy at 44% CAGR, Florens Fresh at 95% YoY), contrasted with declining revenues at Radiance KA Sunshine Seven. Insider activity is limited but includes a notable debt forgiveness by Jupiter Neurosciences executives, signaling strong insider alignment. The forward-looking landscape is packed with catalyst-rich events, including critical NCLT hearings for Indian insolvencies and shareholder meetings for major amalgamations, providing a clear calendar for event-driven strategies.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — August 27, 2026

Today's filings reveal a market dominated by corporate restructuring, capital allocation shifts, and mixed earnings results. A notable theme is the significant insider selling at Sea Ltd across multiple C-suite executives, totaling over $5.4 million, which raises concerns about management conviction despite the company's strong market position. On the earnings front, a divergence is clear: Salesforce and CrowdStrike show strong revenue growth and improving profitability, while HP Inc. and Hormel Foods face margin compression from one-time charges and restructuring costs. The capital markets are active, with several companies (Eightco, Healthy Choice Wellness, Serina Therapeutics) pursuing dilutive financing strategies, while KKR faces a $250 million antitrust penalty. A major corporate control event is unfolding at Nexa Resources, with its controlling shareholder agreeing to sell its stake to Boliden. Overall, the data suggests a cautious market environment where companies are aggressively managing balance sheets and insiders are taking profits, while investors should focus on quality names with clear growth trajectories and prudent capital allocation.

23 high priority 27 medium 50 total filings